To avoid this, it is recommended to normalise hyperglycaemia in maternal GCK carriers of an unaffected foetus through the use of insulin therapy (Hattersley et al., 1998; Chakera et al., 2015). The gene discussed is INS; the disease is Hyperglycemia.